CoChat

Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects

Open access
Boyce, M, Warrington, S, Cortezi, B, Zöllner, S, Vauléon, S, Swinkels, D W, Summo, L, Schwoebel, F, Riecke, K · 2016 · British Journal of Pharmacology
Cited by 82

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Abstract

Background and Purpose: Anaemia of chronic disease is characterized by impaired erythropoiesis due to functional iron deficiency, often caused by excessive hepcidin. Lexaptepid pegol, a pegylated structured l‐oligoribonucleotide, binds and inactivates hepcidin. Experimental Approach: We conducted a placebo‐controlled study on the safety, pharmacokinetics and pharmacodynamics of lexaptepid after single and repeated i.v. and s.c. administration to 64 healthy subjects at doses from 0.3 to 4.8 mg·kg−1. Key Results: After treatment with lexaptepid, serum iron concentration and transferrin increased dose‐dependently. Iron increased from approximately 20 μmol·L−1 at baseline by 67% at 8 h after i.v. infusion of 1.2 mg·kg−1 lexaptepid. The pharmacokinetics showed dose‐proportional increases in peak plasma concentrations and moderately over‐proportional increases in systemic exposure. Lexaptepid had no effect on hepcidin production or anti‐drug antibodies. Treatment with lexaptepid was generally safe and well tolerated, with mild and transient transaminase increases at doses ≥2.4 mg·kg−1 and with local injection site reactions after s.c. but not after i.v. administration. Conclusions and Implications: Lexaptepid pegol inhibited hepcidin and dose‐dependently raised serum iron and transferrin saturation. The compound is being further developed to treat anaemia of chronic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/bph.13433

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 19 references

Research works printed but not linked: 12

  1. 10.1111/bph.13355 · DOI · Paper page
  2. 10.3324/haematol.2015.133983 · DOI
  3. 10.3324/haematol.2013.084624 · DOI · Paper page
  4. 10.1158/1538-7445.AM2014-3847 · DOI
  5. 10.1007/s00467-006-0405-y · DOI
  6. 10.1373/clinchem.2010.149187 · DOI · Paper page
  7. 10.1093/ndt/17.suppl_11.39 · DOI · Paper page
  8. 10.1093/nar/gkt1143 · DOI · Paper page
  9. 10.1016/j.amjmed.2012.01.015 · DOI · Paper page
  10. 10.1371/journal.pone.0002706 · DOI · Paper page
  11. 10.1016/j.bbagen.2010.03.011 · DOI · Paper page
  12. 10.1208/s12248-010-9222-0 · DOI

Cited by

See all 82

Metadata

Authors
Boyce, M., Warrington, S., Cortezi, B., Zöllner, S., Vauléon, S., Swinkels, D. W., Summo, L., Schwoebel, F., & Riecke, K.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2016-04-08
Volume
173
Issue
10
Pages
1580-1588
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2237988842
Cited by
82
References
19
FWCI
7.11
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects. https://app.cochat.ai/papers/10.1111/bph.13433
The paper
Boyce, M., Warrington, S., Cortezi, B., Zöllner, S., Vauléon, S., Swinkels, D. W., Summo, L., Schwoebel, F., & Riecke, K. (2016). Safety, pharmacokinetics and pharmacodynamics of the anti‐hepcidin Spiegelmer lexaptepid pegol in healthy subjects. British Journal of Pharmacology. https://doi.org/10.1111/bph.13433

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.